OVARY CANCER
Clinical trials for OVARY CANCER explained in plain language.
Never miss a new study
Get alerted when new OVARY CANCER trials appear
Sign up with your email to follow new studies for OVARY CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental cancer drug trial halted early
Disease control TerminatedThis study tested a new drug called NUV-868, alone or with other cancer drugs (olaparib or enzalutamide), in 82 adults with advanced solid tumors like ovarian, pancreatic, prostate, or breast cancer. The main goals were to check safety and find the right dose. The trial was stopp…
Matched conditions: OVARY CANCER
Phase: PHASE1 • Sponsor: Nuvation Bio Inc. • Aim: Disease control
Last updated May 26, 2026 04:29 UTC
-
Ovarian cancer drug combo trial halted early
Disease control TerminatedThis early-phase study tested a new drug (STRO-002) combined with bevacizumab in people with advanced ovarian, fallopian tube, or primary peritoneal cancer. The goal was to check safety and find the right dose. The study was stopped early, so results are limited.
Matched conditions: OVARY CANCER
Phase: PHASE1 • Sponsor: Sutro Biopharma, Inc. • Aim: Disease control
Last updated May 19, 2026 11:47 UTC